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Abstract
Objectives:		Several	cross-sectional	studies	have	reported	on	the	prevalence	of	diabetes	in	India.	However,	
there	are	virtually	no	longitudinal	population-based	studies	on	the	incidence	of	diabetes	from	India.	The	
aim	of	 the	 study	was	 to	determine	 the	 incidence	of	diabetes	and	prediabetes	 in	an	urban	south	 Indian	
population.	
Methods:	The	Chennai	Urban	Population	Study	[CUPS],	an	ongoing	epidemiological	study	in	two	residential	
colonies	in	Chennai	[the	largest	city	in	southern	India,	formerly	called	Madras]	was	launched	in	1996;	the	
baseline	study	was	completed	 in	1997.	Follow-up	examination	was	performed	after	a	mean	period	of	8	
years.	At	follow-up,	501	[47.0%]	subjects	had	moved	out	of	this	colonies	and		were	lost	to	follow-up.	Of	the	
remaining	564	individuals,	513	[90.9%]	provided	blood	samples	for	biochemical	analysis.	Regression	analysis	
was	done	using	incident	diabetes	as	dependant	variable	to	identify	factors	associated	with	development	of	
diabetes	or	pre-diabetes.	
Results:	Among	subjects	with	normal	glucose	tolerance	(NGT)	at	baseline	[n=476],	64	(13.4%)	developed	
diabetes	and	48	(10.1%)	developed	pre-diabetes	(IGT	or	IFG).	The	incidence	rate	of	diabetes	was	20.2	per	1000	
person	years	and	that	of	pre-diabetes	was	13.1	per	1000	person	years	among	subjects	with	NGT.	Of	the	37	
individuals	who	were	pre-diabetic	at	baseline,	15	(40.5%)	developed	diabetes	[incidence	rate:	64.8	per	1000	
person	years],	16	(43.2%)	remained	as	pre-diabetic	and	6	(16.2%)	reverted	to	normal	during	the	follow-up	
period.	Regression	analysis	revealed	obesity	[Odds	Ratio	(OR):	2.1,	p=0.001],	abdominal	obesity	[OR:	2.23,	
p<0.001]	and	hypertension	[OR:	2.57,	p<0.001]	to	be	significantly	associated	with	incident	diabetes.	The	Indian	
Diabetes	Risk	Score	(IDRS)	showed	the	strongest	association	with	incident	diabetes	[OR:	5.14,	p<0.001].
Conclusion:	 	The	 study	 shows	 that	 the	 incidence	of	diabetes	 is	very	high	among	urban	 south	 Indians.	
While	obesity,	abdominal	obesity	and	hypertension	were	associated	with	incident	diabetes,	IDRS	was	the	
strongest	predictor	of	 incident	of	diabetes	 in	
this	population.	©
The	Diabetes	Atlas	published	by	 the	 International	 Diabetes	 Federation	 shows	 that	 India	 currently	
leads	the	world	in	number	of	people	with	diabetes	and	
is	currently	home	to	over	40	million	diabetic	subjects.	
These	numbers	are	predicted	to	increase	to	69	million	by	
2025.1	Furthermore,	India	occupies	the	second	position	
with	respect	to	the	number	of	subjects	with	impaired	
glucose	 tolerance	 (IGT).1	 The	 above	 data	 has	 been	
compiled	from	several	cross	sectional	studies	done	in	
various	parts	of	India.2-4	However,	to	date,	there	is	no	
longitudinal	study	on	the	incidence	of	diabetes	or	IGT	
in	India.	This	paper	reports	on	a	eight	year	follow	up	
study	and	presents	the	first	incidence	data	on	diabetes	
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and	prediabetes	from	India.		
MetHODS 
Baseline study
The	Chennai	Urban	Population	 Study	 [CUPS]	 is	
an	ongoing	epidemiological	 study	 conducted	 in	 two	
residential	colonies	representing	the	middle	and	lower	
income	groups	in	Chennai	[the	largest	city	in	southern	
India,	 formerly	 called	Madras].	CUPS	was	 started	 in	
1996	and	the	baseline	study	was	completed	in	1997.	The	
methodological	details	and	several	reports	from	CUPS	
have	already	been	published.5-8	Briefly,	all	individuals	≥ 
20	years	of	age	living	in	these	two	colonies	were	invited	
to	participate	in	a	screening	programme	for	diabetes	and	
the	overall	response	rate	was	90.2%.5  
The	baseline	study	included	anthropometry	[weight,	
height,	waist	and	hip]	and	blood	pressure	measurements	
using	 standard	methods.5	 The	 fasting	 sample	was	
obtained,	after	ensuring	8	hours	of	overnight	fast,	for	
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estimation	of	glucose	and	lipids	following	this,	an	oral	
glucose	load	[75	gm]	was	administered	to	all	individuals	
[excluding	known	diabetic	subjects].5	All	biochemical	
assays	 (plasma	glucose	 and	 lipids)	were	done	using	
Hitachi	912	Autoanalyser	 (Roche	Diagnostics	GmbH,	
Mannheim,	Germany)	utilizing	kits	supplied	by	Roche	
Diagnostics	GmbH	(Mannheim,	Germany).	Individuals	
were	categorized	based	on	a	validated	physical	activity	
[PA]	questionnaire	as	having	light,	moderate	or	heavy	
activity.5,8	Of	 the	 1262	 subjects	 recruited	 at	 baseline,	
152	had	diabetes	and	were	excluded	from	follow-up.	
Of	the	remaining	1110	individuals	with	either	normal	
glucose	tolerance	(NGT)	or	IGT	at	baseline,	49	[4.4%]	
died	during	the	follow-up	period,	leaving	a	total	of	1061	
study	subjects.
Follow-up data on incidence of diabetes
Follow-up	examination	was	performed	after	a	mean	
period	of	 8	years.	At	 follow-up,	 497	 (46.8%)	 subjects	
had	moved	out	of	the	colonies	and	were	deemed	lost	to	
follow-up	after	repeated	attempts	to	trace	them	proved	
futile.	Of	the	remaining	564	individuals	still	 living	in	
the	two	colonies,	513	(90.9%)	participated	in	this	study.	
The	flow	chart	of	the	baseline	and	follow-up	status	of	
the	study	cohort	is	shown	in	Fig.	1.	
Of	 the	 513	 respondents,	 37	 had	 been	diagnosed	
to	 have	diabetes	 by	 a	 physician	 and	were	 on	drug	
treatment	 for	 the	 same.	These	 37	 subjects	 provided	
fasting	and	post	prandial	plasma	glucose	samples.	Of	
the	 remaining	 476	 subjects,	 340	 (71.5%)	 individuals	
agreed	to	undergo	an	oral	glucose	tolerance	test	(OGTT),	
while	the	remaining	136	individuals	agreed	for	a	fasting	
plasma	glucose	estimation.																																																												
Definitions
Diabetes:	 Diabetes	was	 diagnosed	 if	 the	 fasting	
plasma	glucose	was	≥	126	mg/dl	(≥	7	mmol/l)	or	2	hour	
post	glucose	was	≥	200	mg/dl	(≥	11.1	mmol/l).9 
Pre-diabetes: Pre-diabetes was	 diagnosed	 if	 the	
fasting	plasma	glucose	was	≥	110	(≥	6.1	mmol/l)	and	
<126	mg/dl	(<7	mmol/l)	–	impaired	fasting	glycemia	
(IFG)	or	2	hour	post	glucose	was	≥	140	mg/dl	 (≥	7.8	
mmol/l)	and	<200	mg/dl	(<11.1	mmol/l)	–	 impaired	
glucose	tolerance	(IGT).10 
Indian Diabetes Risk Score: The	 Indian	Diabetes	
Risk	 Score	 (IDRS)	 described	 by	Mohan	 et al11	was	
calculated	 in	all	 individuals	 as	described	previously.	
IDRS	is	calculated	using	four	simple	parameters,	age,	
family	history	of	diabetes,	physical	activity	and	waist	
circumference.11
Statistical Analysis:
All	the	data	were	computed	and	statistical	analyses	
was	done	using	 the	 SPSS	PC	Windows	version	 10.0	
(Chicago,	 IL).	Students	“t”	 test	was	used	 to	compare	
means	between	groups.	Chi	 square	 test	was	used	 to	
compare	 proportions.	 Triglyceride	 values	were	 log	
transformed	to	obtain	normal	distribution.	Regression	
analysis	was	used	 to	 assess	 factors	 associated	with	
development	of	diabetes.	Cox	regression	analysis	was	
used	to	determine	the	effect	of	various	risk	factors	on	
diabetes.	 Survival	 curves	were	plotted	 by	 life	 table	
analysis	and	those	of	subjects	with	and	without	IGT	at	
baseline	and	subjects	with	different	IDRS	scores	were	
compared	using	Wilcoxon	 [Gehan]	 test.	 p<0.05	was	
considered	to	be	statistically	significant.
ReSULtS
There	was	no	significant	difference	 in	 the	baseline	
characteristics	of	the	current	residents	of	the	colonies	
(n=564)	 and	 those	 lost	 to	 follow-up	 (n=497).	Current	
residents	vs.	 lost	 to	 follow-up:	 age:	 41±13	vs.	 40±15	
years,	p=0.451;	 body	mass	 index	 (BMI):	 22.4±4.2	vs.	
22.2±4.6	kg/m2,	p=0.343;	waist	circumference:	76.0±12.6	
vs.	75.5±13.4	cm,	p=0.517	and	fasting	plasma	glucose:	
76±17	vs.	 75±19	mg/dl,	 p=0.265.	 The	proportion	of	
subjects	with	impaired	glucose	tolerance	(IGT)	was	also	
not	significantly	different;	current	residents	vs.	lost	to	
follow-up:	39	(6.9%)	vs.	34	(6.8%),	p=0.962].  
Among	the	current	residents	(n	=	564),	51	individuals	
refused	to	participate	in	the	study.	The	comparison	of	
the	responders	(n	=	513)	with	the	non-responders	(n	=	
51)	showed	no	significant	difference	 in	 their	baseline	
characteristics	 except	 for	 age.	Responders	 vs.	 non-
responders;	age:	40±13	vs.	46±17	years,	p=0.002;	BMI:	
22.5±4.2	 kg/m2 vs.	 21.6±3.8	 kg/m2,	 p=0.136;	waist	
circumference:	76.3±12.6	cm	vs.	73.1±12.7	cm,	p=0.080,	
fasting	plasma	glucose:	 76±17	mg/dl	vs.	 73±16	mg/
dl,	p=0.132,	systolic	blood	pressure	(120±16	mmHg	vs.	
123±16	mmHg,	p=0.147)	and	diastolic	blood	pressure	
(78±9	mmHg	vs.	80±11	mmHg,	p=0.181).	The	proportion	
of	subjects	with	IGT	was	also	not	significantly	different	
between	the	responders	and	non-responders:	7.2%		vs	
3.9%,	p=0.377.	
During	 the	mean	 follow	up	period	of	8±1.3	years,	
overall	79/513	(15.4%)	developed	diabetes,	yielding	an	
incidence	rate	of	diabetes	of	20.2	per	1,000	person	years	
[79/3912X1000].		
Among	NGT	subjects	at	baseline	[n=476],	64	(13.4%)	
developed	diabetes	 and	 48	 (10.1%)	developed	pre-
diabetes.	Thus	 the	 incidence	 rate	of	diabetes	 among	
NGT	subjects	was	17.5	per	1000	person	years	[64/3665	
X1000]	for	diabetes	and	13.1	per	1000	person	years	for	
pre-diabetes	[48/3665X1000].	
Of	 the	 37	pre-diabetic	 individuals	 at	 baseline,	 15	
(40.5%)	developed	diabetes	 (incidence	 rate:	 64.8	per	
1000	person	years	[16/247X1000]),	16	(43.2%)	remained	
pre-diabetic	and	6	(16.2%)	reverted	to	normal	during	
the	 follow-up	period.	The	proportion	of	pre-diabetic	
subjects	 at	 baseline	who	developed	diabetes	 [40.5%]	
was	significantly	higher	compared	to	the	NGT	subjects	
[13.4%]	at	baseline	[p<0.0001]	[Fig.	1].
Table	 1	 compares	 the	 characteristics	 of	 the	NGT	
subjects	at	baseline	who	converted	to	diabetes	and	pre-
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diabetes	at	follow-up	compared	to	those	who	maintained	
as	NGT.	Compared	with	 the	 “non-converters”,	 the	
“converters”	were	older	at	follow-up	[p<0.05]	and	had	
increased	BMI	[p<0.05],	waist	circumference	[p<0.05],	
systolic	blood	pressure	[p<0.05],	diastolic	blood	pressure	
[p<0.05]	 and	 fasting	plasma	glucose	 [p<0.05].	Mean	
IDRS	value	was	higher	among	converters	compared	to	
non-converters.	Moreover,	 the	proportion	of	 subjects	
with	IDRS	≥	60	was	higher	among	converters	compared	
to	non-converters.
Incidence	of	diabetes	at	follow-up	(per	1000	person	
years)	increased	with	age	at	baseline:	age:	20-29	years:	
10.3;	30-39	years:	20.7;	age:	40-49	years:	25.2	and	≥	50	
years:	23.4.	
Table	2	 shows	 the	 clinical	 and	biochemical	 factors	
associated	with	 conversion	 to	 diabetes	 from	 either	
NGT	or	pre-diabetes	status.	The	proportion	of	subjects	
developing	diabetes	was	 significantly	higher	 among	
subjects	with	one	parent	diabetic	[20.7%]	as	compared	
with	neither	parent	diabetic,	and	still	higher	in	subjects	
with	both	parents	diabetic	[35.7%].	More	obese	subjects	
[24.5%]	converted	to	diabetes	than	non-obese	subjects	
[12%].	More	subjects	with	abdominal	obesity	 [28.1%]	
converted	than	those	without	abdominal	obesity	[10.7%]	
at	baseline.	Subjects	with	hypertension	at	baseline	had	
significantly	higher	prevalence	of	diabetes	 at	 follow-
up.	However,	there	was	no	significant	difference	in	the	
proportion	of	 subjects	who	developed	diabetes	with	
reference	to	physical	activity	at	baseline.	
Table	2	also	shows	the	relative	risk	(RR)	for	diabetes	
based	on	various	parameters.	 Subjects	with	 obesity	
at	baseline	had	a	relative	risk	of	2.1	for	diabetes	[95%	
confidence	interval	(95%	CI):	1.35	–	3.29].	Introducing	
age	 and	gender	 into	 the	model	did	not	 significantly	
alter	 the	 results.	 Similar	 results	were	observed	with	
abdominal	obesity.	However,	family	history	of	diabetes,	
hypertriglyceridemia	and	hypercholesterolemia	failed	to	
show	an	association	with	diabetes	in	this	model.	Subjects	
with	IDRS	≥	60	at	baseline	had	the	highest	proportion	of	
conversion	to	diabetes	(27.8%)	compared	to	those	with	
score	of	30-50	(16.9%)	and	<30	(5.6%)	p<0.001.	Moreover,	
38.4%	of	‘converters’	to	either	diabetes	or	pre-diabetes	
had	IDRS	≥	60	at	baseline.		We	computed	the	relative	
risk	for	IDRS	and	observed	that	IDRS	had	a	significant	
association	with	diabetes	even	after	adjusting	for	age	
and	gender	[Table	2],	[IDRS	≥	60:	RR	3.1,	p=0.035,	IDRS	
30	–	50:	RR	2.7,	p=0.032].
The	 life	 table	 analysis	 using	Wilcoxon	 (Gehan)	
statistic	test	revealed	a	statistically	significant	difference	
in	development	of	diabetes	between	subjects	with	IDRS	
≥	60	compared	to	those	with	IDRS	30-50	and	IDRS	<30	
[p=0.0003] [Fig.	2].
DISCUSSIOn 
This	is	the	first	study	to	our	knowledge,	to	present	
the	 incidence	of	diabetes	and	prediabetes	 in	 Indians.	
This	is	significant,	given	that	India	is	the	epicentre	of	
Fig.1 : Flow chart showing the baseline and follow-up status of the study 
cohort
table 1 : Baseline characteristics of the nGt subjects based on their glycemic status at follow-up
	 Remained	as	NGT	 Converters	to	 Converters	to	 
	 (NGT	to	NGT)	 Pre-diabetes		 Diabetes	  
	 [n	=	364]	 (NGT	to	IFG	or	IGT)	 (NGT	to	DM)
	 	 [n	=	48]	 	[n	=	64]
Age	(yrs)	 38	±	12	 45	±	13	*		 43	±	14	*
BMI	(kg/m2)	 21.8	±	4.1	 23.5	±	3.4	*	 24.4	±	4.4	*
Waist	circumference	(cm)	 74.2	±	11.9	 78.7	±	13.7	*	 82.2	±	11.8	*
Waist-to-hip	ratio	 0.83	±	0.08	 0.85	±	0.08	 0.89	±	0.11	*#
Systolic	BP	(mm	Hg)	 118	±	16	 122	±	15		 127	±	19	*
Diastolic	BP	(mm	Hg)	 77	±	9	 79	±	8		 81	±	11	*	
Fasting	plasma	glucose	(mg/dl)	 75	±	13	 81 ±	14	* 81	±	18	*
Serum	cholesterol	(mg/dl)	 167	±	41	 179	±	38		 169	±	56	
Serum	triglycerides	(mg/dl)	 110	±	69	 121	±	62	 115	±	60	
HDL	cholesterol	(mg/dl)	 39	±	11	 41	±	11	 36	±	16
Family	history	of	diabetes	n(%)	 59	(16.2)	 13	(27.1)	 18	(28.1)	*
Mean	Indian	diabetes	 35.7	±	15.7	 44.2	±	13.7	*	 45.1	±	15.0	*	 
	 risk	score	(IDRS)	
Subjects	with	IDRS	score	≥	60	n(%)	 38	(10.4)	 7	(14.6)	 15	(23.8)	*
*	p<0.05	compared	to	subjects	who	remained	as	NGT	and	#	p<0.05	compared	to	converters	to	IGT
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the	world’s	diabetes	epidemic.	The	main	findings	of	this	
study	are:	(1)	incidence	of	diabetes	in	this	urban	south	
Indian	population	was	20.2	per	1,000	person	years,	(2)	
incidence	 of	pre-diabetes	was	 13.1	per	 1,000	person	
years,	 (3)	 incidence	of	diabetes	 among	 subjects	with	
IGT	at	baseline	was	higher	compared	to	those	with	NGT	
and	(4)	the	Indian	Diabetes	Risk	Score	(IDRS)	developed	
by	us	seems	to	be	the	best	predictive	tool	of	 incident	
diabetes	in	Asian	Indians.
Other	studies	have	examined	the	progression	from	
IGT	to	diabetes.	A	study	from	Baltimore	reported	that	
17%	of	subjects	with	IGT	progressed	to	diabetes	during	
10	years	of	follow	up.12	Similar	results	were	observed	
in	Taiwan.13	In	the	present	study,	over	40%	of	subjects	
with	IGT	at	baseline	developed	diabetes	during	8	years	
of	follow-up,	translating	to	an	incidence	rate	of	64.8	per	
1000	person-years	which	is	very	high.
In	terms	of	overall	incidence,	Dowse	et al	found	that	
among	Pacific	 and	 Indian	Ocean	populations,	 Pima	
Indians	 (Native	Americans)	had	 the	highest	diabetes	
incidence	rate	(15	per	1000	cases	per	1000	person-years)	
along	with	 rural	Wanigelas,	 (Papua	New	Guinea),	
Nauruans	 (Micronesia),	 urban	 Samoans	 and	finally	
Asian	 Indians	 in	Mauritius.14	 In	 the	 present	 study,	
the	 incidence	 rate	 among	NGT	 at	 baseline	 subjects	
was	17.5	per	1000	person-years.	Both	this	and	Dowse	
et	 al’s	findings	 from	other	Pacific	 and	 Indian	Ocean	
populations	are	much	higher		than		what		is		reported	
from	other	ethnic		groups,15	-17	suggesting	once	again	the	
existence	of	the	so	called	‘Asian	Indian	Phenotype’18,19 
with	an	increased	susceptibility	to	diabetes.
In	an	earlier	clinic	based	study	conducted	in	South	
India,	we	showed	that	one-	third	of	IGT	subjects,	while	
one-third	 remained	 as	 IGT	 and	 one-third	 reverted	
back	 to	normal.20	 In	 another	 clinic	 based	 study,21	 54	
individuals	with	IGT	were	followed		for	a	median	of	7.0	
years,	14	(25.9%)	developed	diabetes	and	16.2%	reverted	
to	 normal.	 In	 the	 present	 study,	 40.5%	 developed	
Fig. 2 : Incidence of diabetes in relation to Indian Diabetes Risk Score 
(IDRS)
table 2 : Proportion and relative risk for diabetes based on various parameters 
Details		 Proportion	of	 RR	[95%	CI]		 RR	[95%	CI],	p	values
	 	diabetes		 [Unadjusted],	p	values	 [Adjusted	for	age	and	gender]
Obesity
No	 12.0%	 1.0	 1.0
Yes	 24.5%**	 2.1	[1.35	–	3.29],	0.001	 1.93	[1.29	–	3.04],	0.001
Abdominal obesity 
No	 10.7%	 1.0	 1.0
Yes	 28.1%*	 2.23	[1.49	–	3.34],	<	0.001		 2.0	[1.33	–	3.0],	0.001	
Family history of diabetes
None	 13.6%	 1.0
Either	parent	 20.7%	 1.26	[0.78	–	2.03],	0.355	 1.01.38	[0.84	–	2.24],	0.200
Both	parents	 35.7%	##	 1.30	[0.47	–	3.56],	0.615	 1.51	[0.55	–	4.18],	0.428
Physical activity
Heavy	 17.3%	 1.0	 1.0
Moderate	 12.3%	 0.86	[0.50	–	1.50],	0.602	 0.85	[0.49	–	1.48],	0.563
Light	 16.5%	 1.03	[1.01	–	1.04],	0.922	 0.91	[0.55	–	1.52],	0.721
Hypertension
No	 12.6%	 1.0	 1.0
Yes	 29.4%*	 2.57	[1.60	–	4.14],	<	0.001	 2.42	[1.42	–	4.12],	0.001
Hypercholesterolemia
No	 14.8%	 1.0	 1.0
Yes	 17.5%	 1.12	[0.67	–	1.86],	0.662	 0.96	[0.57	–	1.62],	0.887
Hypertriglyceridemia
No	 14.4%	 1.0	 1.0
Yes	 19.4%*	 1.36	[0.82	–	2.26],	0.231	 1.34	[0.80	–	2.24],	0.267
IDRS* Score
<30	 5.6%	 1.0	 1.0
30-50	 16.9%	 3.65	[1.76	–	7.60],	0.001	 3.02	[1.34	–	6.82],	0.008
≥	60	 27.8%#	 5.14	[2.26	–	11.68],	<	0.001	 4.10	[1.64	-	10.22],	0.002
*	p	<	0.001,	**	p	=	0.001	compared	to	their	counterparts.	##	p	for	trend	<	0.001,	#	p	for	trend	=	0.011.	*	Indian	Diabetes	Risk	Score11
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diabetes	and	33.4%	reverted	to	normal.	This	difference	in	
conversion	rates	could	be	due	to	the	marked	changes	in	
environmental	factors	over	the	past	10	years.	Moreover	
only	the	present	study	is	population	based.	
Determining	 the	 conversion	 rates	 to	diabetes	 in	 a	
population	is	important	as	it	reveals	the	future	burden	
of	diabetes.	According	 to	 the	 International	Diabetes	
Federation	report,	presently	India	has	35.9	million	IGT	
subjects.	We	 found	 that	 the	 incidence	of	diabetes	 in	
subjects	with	IGT	is	64.8	/	1000	person	years.	Thus,	in	
a	period	of	one	year,	2.2	million	subjects	with	IGT	will	
likely	convert	to	diabetes.	In	addition,	the	present	study	
shows	that	another	1.7	million	people,	currently	with	
NGT	status,	will	convert	 in	one	year.	These	numbers	
suggest	a	dramatic	increase	and	an	alarming	health	and	
economic	threat	due	to	diabetes	in	India.	
Given	that	diabetes	is	an	expensive	and	debilitating	
disease,	it	is	worthwhile	to	look	for	risk	factors	associated	
with	 incident	diabetes.	 In	 this	 study,	 age,	waist	 (that	
is,	 abdominal	 obesity)	 and	BMI	 (that	 is,	 generalized	
obesity)	are	seen	to	be	causative	factors.	Earlier	studies	
also	strongly	implicated	both	generalized	and	abdominal	
obesity	as	risk	factors	for	diabetes.	Intervention	studies	
have	proved	that	a	5-7%	reduction	in	the	weight	of	high-
risk	subjects	could	produce	a	decline	in	the	incidence	
of	diabetes.22	To	put	this	information	to	use,	we	need	
to	 identify	high-risk	 individuals	 to	prevent	or	delay	
the	onset	of	diabetes.	Screening	a	whole	population	to	
identify	undiagnosed	diabetic	subjects	may	be	expensive	
and	laborious.	Hence,	recent	studies	have	focused	on	
diabetes	 risk	 scores	 for	opportunistic	 screening.	The	
Indian	Diabetes	Risk	Score	(IDRS)	was	derived	by	us	
as	 a	 simple	 tool	 for	detecting	undiagnosed	diabetes	
with	 sensitivity	of	 72.5%	and	a	 specificity	of	 60.1%.11 
In	 this	 study,	 IDRS	 showed	 the	 strongest	 association	
with	diabetes.	The	 risk	 contributed	by	 IDRS	≥	 60	 at	
baseline	was	 3	 times	higher	 than	 that	 from	 low-risk	
subjects	 (IDRS	<30).	Moderate	 risk	 subjects	 (IDRS	30	
-	50)	had	2	times	higher	risk	for	diabetes	compared	to	
those	with	low	risk	(IDRS	<30).	This	indicates	that	IDRS	
has	excellent	predictive	value	for	diabetes	and	is	much	
stronger	than	examining	risk	factors	individually.	IDRS	
is	therefore,	more	suitable	for	opportunistic	screening.	
In	addition,	it	can	help	to	identify	metabolic	syndrome	
and	coronary	artery	disease.23 
The	limitations	of	this	study	are	(1)	the	small	numbers	
of	subjects	studied	and	(2)	follow-up	rate	of	53.2%	due	
to	constant	migration	of	the	population.	However,	those	
lost	to	follow-up	were	not	significantly	different	from	
those	 retained	 in	 the	 study.	Hence,	we	presume	 that	
this	would	not	have	 significantly	affected	 the	 results	
of	the	study.	The	strength	of	this	study	is	that	it	is	the	
first	longitudinal	population	based	study	from	India	to	
report	on	incidence	rates	of	diabetes	and	prediabetes.
In	conclusion,	this	study	reports	that	incidence	rates	
of	diabetes	and	prediabetes	in	India	are	higher	compared	
to	other	ethnic	groups	and	western	populations	and	that	
the	Indian	Diabetes	Risk	Score	(IDRS)	is	perhaps	the	best	
predictor	of	incident	diabetes	among	Asian	Indians.
Acknowledgements
Heather	 Lanthorn	 is	 a	 Fulbright	 Scholar	 from	
USA	who	worked	 at	 the	Madras	Diabetes	Research	
Foundation.	This	is	the	19th	publication	from	the	Chennai	
Urban	Population	Study	(CUPS	–	19).
ReFeRenCeS
1.	 Sicree	R,	 Shaw	 J,	Zimmet	P.	Diabetes	 and	 impaired	glucose	
tolerance	 in	 India.	Diabetes	Atlas.	Gan	D	 	Ed.	 International	
Diabetes	Federation,	2006:	pp	15-103.
2. Ramachandran	A, Snehalatha	C, Kapur	A, Vijay	V, Mohan	V, Das	
AK, et al. Diabetes	Epidemiology	Study	Group	in	India	(DESI). 
High	prevalence	of	diabetes	and	impaired	glucose	tolerance	in	
India:	National	Urban	Diabetes	Survey.	Diabetologia	2001;44:1094-
101.	
3.	 Mohan	V,	Deepa	M,	Deepa	R,	Shanthirani	CS,	Farooq	S,	Ganesan	
A,	Datta	M.	Secular	 trends	 in	 the	prevalence	of	diabetes	 and	
impaired	glucose	tolerance	in	urban	south	India	–	the	Chennai	
Urban	Rural	 Epidemiology	 Study	 (CURES-17).	Diabetologia 
2006;49:1175-78.
4.	 Sadikot	SM,	Nigam	A,	Das	S,	Bajaj	S,	Zargar	AH,	Prasannakumar	
KM,	et al.	DiabetesIndia.	The	burden	of	diabetes	and	impaired	
glucose	 tolerance	 in	 India	 using	 the	WHO	 1999	 criteria:	
prevalence	of	diabetes	in	India	study	(PODIS).	Diabetes Res Clin 
Pract	2004;	66:	301-7.
5.	 Mohan	V,	Shanthirani	S,	Deepa	R,	Premalatha	G,	Sastry	NG,	
Saroja	 R.	 Intra	 urban	 differences	 in	 the	 prevalence	 of	 the	
metabolic	 syndrome	 in	 southern	 India	–	The	Chennai	Urban	
Population	Study	(CUPS).	Diabet Med	2001;18;280-87.
6.	 Mohan	V,	Shanthirani	CS,	Deepa	R.	Glucose	intolerance	(diabetes	
and	 IGT)	 in	 a	 selected	 south	 Indian	population	with	 special	
reference	 to	 family	history,	obesity	and	 lifestyle	 factors	–	The	
Chennai	Urban	Population	Study	(CUPS	14).	J Assoc Physician 
India	2003;51:771–77.
7.	 Mohan	V,	Deepa	R,	Shanthirani	S,	Premalatha	G.	Prevalence	of	
coronary	artery	disease	and	its	relationship	to	lipids	in	a	selected	
population	in	south	India.	The	Chennai	Urban	population	Study	
(CUPS	No.	5).	J Am Coll Cardiol	2001;38:682–87.
8.	 Mohan	V,	Gokulakrishnan	K,	Deepa	R,	Shanthirani	CS,	Datta	M.	
Association	of	physical	inactivity	with	components	of	metabolic	
syndrome	and	 coronary	 artery	disease—the	Chennai	Urban	
Population	Study	(CUPS	No.	15).	Diabet Med	2005;22:1206–11.
9.	 Alberti	KG,	Zimmet	PZ.	Definition	diagnosis	and	classification	
of	diabetes	mellitus	and	its	complications.	Part	1:	Diagnosis	and	
classification	of	diabetes	mellitus,	provisional	report	of	a	WHO	
Consultation.	Diabet Med	1998;15:539-53.
10.	 American	Diabetes	Association:	Screening	for	 type	2	diabetes	
(Position	Statement).	Diabetes Care	2000;23	(Suppl.	1):	S20-S23
11.	 Mohan	V,	Deepa	R,	Deepa	M,	 Somannavar	 S,	Datta	M.	A	
simplified	Indian	Diabetes	Score	for	screening	for	undiagnosed	
diabetic	 subjects.	 Journal of Association of Physicians of India 
2005;53:759-63.
12.	 Meigs	JB,	Muller	DC,	Nathan	DM,	Blake	DR,	Andres	R.	Baltimore	
Longitudinal	Study	of	Aging.	The	natural	history	of	progression	
from	normal	glucose	tolerance	to	type	2	diabetes	in	the	Baltimore	
Longitudinal	Study	of	Aging.	Diabetes	2003;	52:1475-84.
13.	 Chou	P,	Li	CL,	Wu	GS,	Tsai	ST.	Progression	to	type	2	diabetes	
among	 high-risk	 groups	 in	Kin-Chen,	 Kinmen.	 Exploring	
the	natural	history	of	 type	2	diabetes.	Diabetes Care	 1998;	 21: 
1183-87.
14.	 Dowse	GK.	Incidence	of	NIDDM	and	the	natural	history	of	IGT	
©	JAPI	 •	 VOL.	56	 •	 MARCH	2008	 www.japi.org	 157
in	Pacific	and	Indian	Ocean	populations.	Diabetes Res Clin Pract 
1996;	34	Suppl:	S45-50.
15.	 Keen	H,	Jarrett	RJ,	McCartney	P.	The	ten-year	follow-up	of	the	
Bedford	 survey	 (1962-1972):	 glucose	 tolerance	 and	diabetes.	
Diabetologia	1982;22:73-78.
16.	 de	Vegt	F,	Dekker	JM,	Jager	A,	Hienkens	E,	Kostense	PJ,	Stehouwer	
CD,	Nijpels	G,	Bouter	LM,	Heine	RJ:	Relation	of	impaired	fasting	
and	postload	glucose	with	incident	type	2	diabetes	in	a	Dutch	
population:	the	Hoorn	Study.	JAMA	2001;285:2109-13.
17.	 Edelstein	SL,	Knowler	WC,	Bain	RP,	et al.	Predictors	of	progression	
from	impaired	glucose	tolerance	to	NIDDM:	an	analysis	of	six	
prospective	studies.	Diabetes	1997;46:701-10.	
18.	 Joshi	SR.	Metabolic	syndrome—emerging	clusters	of	the	Indian	
phenotype.	J Assoc Physicians India	2003;51:445-6.
19.	 Deepa	R,	 Sandeep	 S,	Mohan	V.	Abdominal	 obesity,	 visceral	
fat	and	Type	2	diabetes	-	“Asian	Indian	Phenotype”.	In:	Type	
2	Diabetes	 in	South	Asians	 :	Epidemiology,	Risk	Factors	 and	
Prevention.	Mohan	V,	Gundu	HR	Rao	(Eds),	Under	the	Aegis	
of	SASAT.	Jaypee	Brothers	Medical	Publishers.	2007;p.138-152.
20.	 Ramachandran	A,	Snehalatha	C,	Naik	RA,	Mohan	V,	Shobana	
R,	Viswanathan	M.	Significance	of	impaired	glucose	tolerance	
in	an	Asian	Indian	population:	a	follow-up	study.	Diabetes Res 
Clin Pract	1986;2:173-78.
21.	 Mohan	V,	Barman	KK,	Rajan	VS,	Chari	ST,	Deepa	R.	Natural	
history	of	endocrine	 failure	 in	 tropical	 chronic	pancreatitis	 in	
longitudinal	follow-up	study.	J Gastroenterol Hepatol	2005;20:1927-
34.
22.	 Knowler	WC,	 Barrett-Connor	 E,	 Fowler	 SE,	 et al.	Diabetes	
Prevention	Program	Research	Group.	Reduction	in	the	incidence	
of	type	2	diabetes	with	lifestyle	 intervention	or	metformin.	N 
Engl J Med	2002;346:393-403.
23.	 Mohan	V,	Sandeep	S,	Deepa	M,	Gokulakrishnan	K,	Datta	M,	
Deepa	R.	A	diabetes	risk	score	helps	identify	metabolic	syndrome	
and	cardiovascular	 risk	 in	 Indians-	 the	Chennai	Urban	Rural	
Epidemiology	Study	(CURES-38).	Diabetes and Obesity Metabolism 
2007;9:337-43.
Announcement
The	following	members	were	awarded	the	Fellowship	of	the	ICP	at	Kochi,	APICON	2008
1.	 Dr.	Sunil	Agarwal	 Delhi	 16.	 Dr.	A	Muruganathan	 Tirupur
2.	 Dr.	Madhu	Sudan	Barthwal	 Ranchi	 17.	 Dr	Prabhu	Dyal	Pahwa	 Gurgaon
3.	 Dr.	Richa	Dewan	 New	Delhi	 18.	 Dr.	Abhijit	Pal	 Kolkata
4.	 Dr.	Prof.	Satyabrata	Ganguly	 Kolkata	 19.	 Dr.	Sharad	Kumar	Parashar	 Bhopal
5.	 Dr.	Alok	Kumar	Ghosh	 Kolkata	 20.	 Dr.	Jaising	M	Phadtare	 Mumbai
6.	 Dr.	Soumitra	Ghosh	 Kolkata	 21.	 Dr.	Prakash	K	Pispati	 Mumbai
7.	 Dr.	Rajinder	Singh	Gupta	 Patiala	 22.	 Dr.	Madhukar	Rai	 Varanasi
8.	 Dr.	Arun	Kumar	Jain	 New	Delhi	 23.	 Dr.	Harbir	Kaur	Rao	 Patiala
9.	 Dr.	Charu	K	Jani	 Mumbai	 24.	 Dr.	Anjan	Kumar	Saikia	 Guwahati
10.	 Dr.	Rajiv	Kohli	 New	Delhi	 25.	 Dr.	Jugal	Kishor	Sharma	 New	Delhi
11.	 Dr.	Prof.	Sri	Venkata	Madhu	 Delhi	 26.	 Dr.	Harpreet	Singh	 Rohtak
12.	 Dr.	Suresh	Kumar	Minocha	 Dehradun	 27.	 Dr.	Veer	Bahadur	Singh	 Bikaner
13.	 Dr.	Manoranjan	Mahapatra	 New	Delhi	 28.	 Dr.	Navin	Kumar	Soni	 Ghaziabad
14.	 Dr.	Arvind	Mathur	 Jodhpur	 29.	 Dr.	Dinesh	C	Srivastava	 New	Delhi
15.	 Dr.	Aditya	Prakash	Misra	 New	Delhi	 30.	 Dr.	Amit	Varma	 Dehradun
